, Tracking Stock Market Picks
Enter Symbol:
Cardiome Pharma Corporation (CRME) [hlAlert]

Sector Perform
down 68.46 %

Cardiome Pharma Corporation (CRME) downgraded to Sector Perform with price target $1.50 by RBC Capital Mkts

Posted on: Tuesday,  Mar 20, 2012  10:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Sector Perform Cardiome Pharma Corporation (NASDAQ: CRME) on 03/20/2012. Previously RBC Capital Mkts rated Outperform Cardiome Pharma Corporation (NASDAQ:
CRME) on 11/07/2011., when the stock price was $14.00. Since then, Cardiome Pharma Corporation has lost 68.46% as of 03/20/2012's recent price of $4.42.
If you would have followed the previous RBC Capital Mkts's recommendation on CRME, you would have lost 68.46% of your investment in 134 days.

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/20/2012 10:25 AM Hold
4.42 7.50
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD down  -66.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/7/2011 9:25 AM Buy
14.00 30.00
4/27/2011 9:25 AM Buy
23.50 40.00
10/22/2010 9:25 AM Hold
28.10 45.00
8/12/2009 9:25 AM Hold
20.15 45.00
8/12/2008 9:25 AM Hold
47.60 57.50
7/16/2008 8:25 AM Hold
52.60 67.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy